1. Home /
  2. Biotechnology


If You're in Neurocrine Biosciences Consider Getting Out: Here's Why

Let's check the charts and indicators.

Here Are 2 Ways I'm Playing the Market With Small-Cap Stocks

I'm going both ways in what I view as an overbought market within a deteriorating economy.

I Found a Good-Looking Arrowhead in This Biotech ETF

Let's review the charts of XBI, the SPDR S&P Biotech ETF.

Does Intellia Therapeutics Stock Have Good Genes?

Let's check on the charts and indicators of the cutting-edge CRISPR editing company.

Amgen Is Casting a Bearish Technical Hue in Advance of Earnings

The biotech giant's charts have displayed weakness of late as it prepares to report fourth-quarter results.

Johnson & Johnson Might Need a Band-Aid Ahead of Earnings

A rally in the shares stalled around $180 in December and early January.

Bearish Bets: 3 Nasdaq Giants You Should Think About Shorting This Week

These stocks are displaying bearish tendencies based on their technical patterns.

This Small Pharma Company Could Develop Into a Nice Trade

Let's see how to trade GlycoMimetics, a clinical-stage drug developer focused on a type of cancer treatment.

Incyte Gets a Quantitative Upgrade

We have two price target areas for this biopharmaceutical firm.

Why Are Insiders Buying These 2 Stocks?

An oncology and a oil & gas concern, new names on my list, have my attention.